Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

  27,432,603      
Direct Value   $8,963,626    

Indirect Value

  $114,702,131      
Total Shares   30,740,788      
Total Value   $123,665,757      


Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $6,665,439 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0 Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $6,665,439 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    6   
    1    

     Stock price went up :

    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ETNB 89bio, Inc. 10% Owner   –       –       •   2019-11-11 4 B $16.00 $9,200,000 I/I 575,000 575,000 1.5 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2019-11-13 4 A $0.00 $0 I/I 1,916,787 2,491,787 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-07-10 4 B $27.50 $2,999,975 I/I 109,090 2,600,877 1.5 %
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-11-16 4 A $0.00 $0 I/I 5,944 891 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-11-16 4 D $0.00 $0 I/I (850,000) 1,750,877 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2015-08-11 4 B $16.00 $5,000,000 I/I 312,500 7,434,630 2.25 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2015-08-11 4 A $0.00 $0 I/I 7,122,130 7,122,130 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2016-03-29 4 B $13.50 $1,089,135 I/I 78,504 7,513,134 2.25 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2016-11-29 4 A $0.00 $0 D/D 7,276 7,276 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2016-11-29 4 D $0.00 $0 I/I (1,500,000) 6,013,134 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2018-02-22 4 B $32.00 $498,976 D/D 15,593 22,869 3.92 -
AIMT Aimmune Therapeutics, Inc... Director   –       •       •   2018-05-23 4 A $0.00 $0 D/D 3,750 26,619 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2019-05-23 4 A $0.00 $0 D/D 6,442 33,061 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2019-09-17 4 A $22.34 $279,216 D/D 12,500 45,561 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-03-17 4 B $11.40 $1,139,650 I/I 100,000 6,113,134 2.1 %
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-03-17 4 B $11.50 $101,051 D/D 8,787 54,348 2.39 %
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-03-18 4 B $11.06 $179,345 D/D 16,213 70,561 2.39 %
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-05-27 4 S $0.00 $0 D/D (7,840) 78,401 0 %
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-09-21 4 A $0.00 $0 I/I 91,697 91,697 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-09-21 4 D $0.00 $0 I/I (6,113,134) 0 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-10 4 D $34.50 $3,163,547 I/I (91,697) 0 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-10 4 D $34.50 $2,434,355 D/D (70,561) 0 0 -
AIMT Aimmune Therapeutics, Inc... Director   –       •      –    2020-10-13 4 D $34.50 $270,480 D/D (7,840) 0 0 -
APTX Aptinyx Inc. Director   –       •      –    2018-06-25 4 B $16.00 $2,400,000 I/I 150,000 3,190,079 2.1 -
APTX Aptinyx Inc. Director   –       •      –    2018-06-25 4 A $0.00 $0 I/I 3,040,079 3,040,079 0 -

  169  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed